Nanoviricides (NNVC) Non Operating Interest Expenses (2013 - 2024)
Nanoviricides' Non Operating Interest Expenses came in at $149.00 for FY2025 (year ended Jun 30, 2025), down 99.7% from $49,808 in FY2024.
Powered by 
Analysis
Nanoviricides (NNVC) Non Operating Interest Expenses (2013 - 2024) Analysis & Trends
Going back to FY2013, Nanoviricides' Non Operating Interest Expenses data covers 12 fiscal years.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of -72.4% (FY2020 to FY2025).
- The FY2025 figure represents the lowest annual Non Operating Interest Expenses in data going back to FY2013.
- Per Business Quant, earlier fiscal years put Non Operating Interest Expenses at $49,808 in FY2024, $938.00 in FY2023 (-81.7%), $5,123 in FY2022 (-94.0%) and $85,405 in FY2021 (-8.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,162.99 Bn | 1,131.58 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 633.71 Bn | 552.23 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 502.40 Bn | 475.51 Bn | 12.70 Bn | - |
| 4 | Merck | 376.48 Bn | 330.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.02 Bn | 240.70 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 240.85 Bn | 196.25 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 193.39 Bn | 167.58 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | - |
| 10 | Nanoviricides | 29.48 Mn | 17.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 149.00 |
| Dec 31, 2023 | 13,315.00 |
| Sep 30, 2023 | 36,493.00 |
| Dec 31, 2022 | 94.00 |
| Sep 30, 2022 | 844.00 |
| Jun 30, 2022 | -927.00 |
| Mar 31, 2022 | 4,789.00 |
| Dec 31, 2021 | 2,631.00 |
| Sep 30, 2021 | 891.00 |
| Jun 30, 2021 | 7,934.00 |
| Mar 31, 2021 | 2,516.00 |
| Dec 31, 2020 | 37,293.00 |
| Sep 30, 2020 | 43,909.00 |
| Jun 30, 2020 | 44,602.00 |
| Mar 31, 2020 | 44,937.00 |
| Dec 31, 2019 | 4,131.00 |
| Jun 30, 2018 | -1.00 |
| Dec 31, 2017 | 60,275.00 |
| Sep 30, 2017 | 125,000.00 |
| Jun 30, 2017 | 125,000.00 |
API Access
Nanoviricides Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();